China Resources Medical Holdings 과거 수익 실적

과거 기준 확인 0/6

China Resources Medical Holdings의 수입은 연평균 -3.9%의 비율로 감소해 온 반면, Healthcare 산업은 수입이 연평균 9%의 비율로 증가했습니다. 매출은 연평균 36.4%의 비율로 증가해 왔습니다. China Resources Medical Holdings의 자기자본이익률은 4.7%이고 순이익률은 2.9%입니다.

주요 정보

-3.9%

수익 성장률

-4.1%

EPS 성장률

Healthcare 산업 성장	11.3%
매출 성장률	36.4%
자기자본 수익률	4.7%
순이익	2.9%
최근 수익 업데이트	30 Jun 2024

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

China Resources Medical Holdings 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

SZSC:1515 수익, 비용 및 수입 (CNY Millions )
날짜	수익	수익	G+A 비용
30 Jun 24	9,970	294	1,069
31 Mar 24	10,039	276	1,061
31 Dec 23	10,108	258	1,053
30 Sep 23	9,958	338	1,025
30 Jun 23	9,809	419	997
31 Mar 23	8,855	342	931
31 Dec 22	7,901	266	864
30 Sep 22	6,891	365	779
30 Jun 22	5,881	463	695
31 Mar 22	5,164	441	630
31 Dec 21	4,447	418	566
30 Sep 21	4,031	410	504
30 Jun 21	3,615	402	441
31 Mar 21	3,183	356	400
31 Dec 20	2,751	310	358
30 Sep 20	2,404	313	306
30 Jun 20	2,058	315	253
31 Mar 20	2,087	353	253
31 Dec 19	2,115	391	254
30 Sep 19	2,112	401	244
30 Jun 19	2,108	412	235
31 Mar 19	2,084	421	229
31 Dec 18	2,059	431	223
30 Sep 18	1,996	364	225
30 Jun 18	1,932	298	227
31 Mar 18	1,905	360	219
31 Dec 17	1,878	421	212
30 Sep 17	1,784	-446	204
30 Jun 17	1,690	-1,312	196
31 Mar 17	1,611	-1,410	184
31 Dec 16	1,533	-1,507	172
30 Sep 16	1,504	-656	167
30 Jun 16	1,475	196	163
31 Mar 16	1,424	181	156
31 Dec 15	1,372	167	150
30 Sep 15	1,337	208	124
30 Jun 15	1,302	249	97
31 Mar 15	1,254	240	91
31 Dec 14	1,206	230	86
30 Sep 14	1,090	176	85
30 Jun 14	975	122	84
31 Mar 14	931	106	79
31 Dec 13	887	90	74

양질의 수익: 1515 에는 CN¥370.2M 큰 일회성 손실이 있습니다. CN¥370.2M 은 지난 12개월 간의 재무 결과에 30th June, 2024 까지 영향을 미쳤습니다.

이익 마진 증가: 1515 의 현재 순이익 이익률 (2.9%) 작년보다 낮습니다 (4.3%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: 1515 의 수입은 지난 5년 동안 매년 3.9% 씩 감소했습니다.

성장 가속화: 1515 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: 1515 은 지난 1년 동안 마이너스 수익 성장( -29.8% )을 기록하여 Healthcare 업계 평균( -16.9% ).

China Resources Medical Holdings 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

Recent updates

Investor sentiment deteriorates as stock falls 18%

Investor sentiment improves as stock rises 19%

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

New minor risk - Profit margin trend

Upcoming dividend of HK$0.055 per share

First half 2024 earnings released: EPS: CN¥0.34 (vs CN¥0.32 in 1H 2023)

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited Announces Interim (Semi-Annual) for the Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 25, 2024

China Resources Medical Holdings Company Limited to Report First Half, 2024 Results on Aug 26, 2024

Now 21% undervalued after recent price drop

China Resources Medical Holdings Company Limited Approves the Final Dividend for the Year Ended December 31, 2023, Payable on July 19, 2024

Upcoming dividend of CN¥0.06 per share

Independent Non-Executive Director recently sold HK$2.6m worth of stock

Dividend of CN¥0.06 announced

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 19 July 2024

China Resources Medical Holdings Company Limited, Annual General Meeting, Jun 05, 2024

Full year 2023 earnings released: EPS: CN¥0.20 (vs CN¥0.11 in FY 2022)

Now 24% undervalued after recent price drop

China Resources Medical Holdings Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Now 20% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

China Resources Medical Holdings Company Limited Announces Board and Committee Changes

First half 2023 earnings released: EPS: CN¥0.32 (vs CN¥0.16 in 1H 2022)

China Resources Medical Holdings Company Limited to Report First Half, 2023 Results on Aug 22, 2023

Investor sentiment deteriorates as stock falls 15%

China Resources Medical Holdings Company Limited Announces Board Changes

China Resources Medical Holdings Company Limited Approves Final Dividend for the Year Ended December 31, 2022, Payable on July 19, 2023

Upcoming dividend of HK$0.037 per share at 0.6% yield

Full year 2022 earnings released: EPS: CN¥0.11 (vs CN¥0.33 in FY 2021)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

China Resources Medical Holdings Company Limited Announces Board Changes

Less than half of directors are independent

First half 2022 earnings released: EPS: CN¥0.16 (vs CN¥0.16 in 1H 2021)

China Resources Medical Holdings Company Limited to Report First Half, 2022 Results on Aug 23, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

China Resources Medical Holdings Company Limited Declares A Final Dividend for the Year Ended December 31, 2021

Upcoming dividend of HK$0.12 per share

Full year 2021 earnings released: EPS: CN¥0.33 (vs CN¥0.25 in FY 2020)

Less than half of directors are independent

China Resources Medical Holdings Company Limited Proposes Final Dividend for Fiscal Year 2021, Payable on or Before July 19, 2022

Investor sentiment improved over the past week

China Resources Medical Holdings Company Limited to Report Fiscal Year 2021 Results on Mar 25, 2022

China Resources Medical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended December 31, 2021

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.16 (vs CN¥0.086 in 1H 2020)

Non-Executive Director Yan Wang has left the company

Independent Non-Executive Director recently sold HK$4.7m worth of stock

Investor sentiment improved over the past week

Upcoming dividend of HK$0.088 per share

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited Proposes Final Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS CN¥0.25 (vs CN¥0.31 in FY 2019)

China Resources Medical Holdings Company Limited to Report Fiscal Year 2020 Results on Mar 26, 2021

New 90-day high: HK$7.35

New 90-day high: HK$6.83

New 90-day high: HK$6.00

New 90-day high: HK$5.69

New 90-day low: HK$4.63

First half earnings released

First half earnings released

New 90-day high - HK$5.81

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률